Pharmagreen Biotech Inc.

0.0019+0.00 (+2.15%)
Oct 28, 4:00:00 PM EDT · OTC Markets OTCPK · PHBI · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
1.26M
P/E (TTM)
-
Basic EPS (TTM)
0.00
Dividend Yield
0%

Recent Filings

About

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

CEO
Mr. Peter Wojcik B.A.
IPO
2/9/2009
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic